MarkEMolitchMD

Endocrinology • Chicago, IL

Diabetes, Lipid Metabolism, Thyroid

Martha Leland Sherwin Professor, Northwestern University Medical School

Join to view full profile

Dr. Molitch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Molitch's full profile

Already have an account?

Office
645 N. Michigan Avenue
Suite 530
Chicago, IL 60611
Phone+1 312-503-4130

Fax+1 312-926-8693

Education & Training

Los Angeles County-Harbor-UCLA Medical CenterResidency, Endocrinology, Diabetes, and Metabolism, 1972 - 1975
University of Pennsylvania Health SystemResidency, Internal Medicine, 1969 - 1972
Perelman School of Medicine at the University of PennsylvaniaClass of 1969

Certifications & Licensure

CA State Medical License 1972 - Present
IL State Medical License 1984 - 2023
FL State Medical License 2019 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Distinguished Educator Award The Endocrine Society, 2013
President The Pituitary Society, 2012-2013
Martha Leland Sherwin Endowed Professorship in Endocrinology Northwestern University, 2011
Martin Luther King Humanitarian Award Northwestern Memorial Hospital, 2009
Humanitarian Global Health Award Institute of Medicine of Chicago, 2008
Physician Clinical Excellence Award Northwestern Medical Faculty Foundation, 2006
Outstanding Physician Educator in Field of Diabetes American Diabetes Association, 1997
Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
Active, not recruiting
Phase 3
Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin Start of enrollment: 2004 Jul 01
Completed
Phase 4
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency Start of enrollment: 2009 Jan 21
Completed
Phase 4
Study of Glycemic Control on Liver Transplantation Outcomes Start of enrollment: 2009 Apr 01
Completed
Phase 4
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Approved for marketing
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes Start of enrollment: 2014 Feb 01
Completed
Phase 3
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease Start of enrollment: 2014 Oct 06
Completed
Phase 3
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable
Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia Start of enrollment: 2018 Mar 27
Terminated
Phase 4
Join now to see all

Publications & Presentations

PubMed

77 citations
Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study
Ian H. de Boer, Xiaoyu Gao, Patricia A. Cleary, Ionut Bebu, John M. Lachin
Clinical Journal of the American Society of Nephrology. 2016-11-07
561 citations
Diagnosis and Treatment of Pituitary Adenomas: A Review
Mark E. Molitch
JAMA. 2017-02-07
477 citations
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
Felipe F. Casanueva, Mark E. Molitch, Janet A. Schlechte, Roger Abs, Vivien Bonert
Clinical Endocrinology. 2006-08-01

Lectures

Endocrine Nurses Society 29th Annual Symposium
ENDO 2019 - New Orleans, LA - 3/23/2019
Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline
ENDO 2019 - New Orleans, LA - 3/23/2019
New Treatments for Type 1 Diabetes and the Pathophysiology of Microvascular Complications
ENDO 2019 - New Orleans, LA - 3/24/2019
Complicated Pituitary Cases from Dr. Molitch's Practice Add to Itinerary
ENDO 2019 - New Orleans, LA - 3/25/2019
Complicated Pituitary Cases from Dr. Molitch's Practice (Repeat)
ENDO 2019 - New Orleans, LA - 3/25/2019
Master Clinician - Beyond-the-Guidelines: Challenging Hyperprolactinoma and Prolactinoma Cases: What the Experts Do
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/20/2018
Pregnancy and Pituitary Tumors
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/17/2018
Clinical Endocrinology Update 2013
The Endocrine Society, New Orleans, Louisiana - 9/26/2013
Clinical Endocrinology Update 2013
The Endocrine Society, New Orleans, Louisiana - 9/26/2013
Endocrine Board Review Course 2013
The Endocrine Society, New Orleans, Louisiana - 9/24/2013
16th Annual Endocrinology & Metabolism Board Review
Cleveland Clinic Foundation Center for Continuing Medical Education, Cleveland, Ohio - 8/16/2013
Management of Type 2 Diabetes in People with Renal Impairment: Clinical Perspectives
Joslin Diabetes Center, Inc., Tampa, Florida - 2/26/2013
Management of Type 2 Diabetes in People with Renal Impairment: Clinical Perspectives
Joslin Diabetes Center, Inc., San Antonio, Texas - 2/6/2013
Management of Type 2 Diabetes in People with Renal Impairment: Clinical Perspectives
Joslin Diabetes Center, Inc., Bethesda, Maryland - 2/5/2013
Comparison of Glycemic and Surgical Outcomes in Cardiac Surgery Patients After Change in Glycemic Targets
Chicago, IL - 6/14/2014
Assessing Current Management of Inpatient Diabetic Ketoacidosis Using Quality Improvement Methodology
Chicago, IL - 6/15/2014
Join now to see all

Press Mentions

Diabetes Drug Has Heart and Kidney Benefits, Researchers FindApril 15th, 2019
Henry Zelada Castro, MD Publishes in Transplantation DirectOctober 2nd, 2018
Longitudinal Service Learning in Medical Education: An Ethical Analysis of the Five-Year Alternative Curriculum at Stritch School of MedicineAugust 6th, 2018
Join now to see all